brexucabtagene autoleucel
gilead
['brexu-cel', 'leusm']
congress | #asco23 | gregory roloff ( ) of reported real-world outcomes amongst 76 adult pts with r/r b-all treated with brexu-cel. high response rates with promising dor were reported; larger cohorts and longer follow-up are warranted #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm